# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001564590-19-008641
Filing Date
2019-03-20
Accepted
2019-03-20 16:05:36
Documents
29
Period of Report
2019-03-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | abio-8k_20190320.htm | 8-K | 32074
2 | EX-99.1 | abio-ex991_8.htm | EX-99.1 | 27422
3 | GRAPHIC | gbzsuoiqma12000004.jpg | GRAPHIC | 206317
4 | GRAPHIC | gbzsuoiqma12000006.jpg | GRAPHIC | 226102
5 | GRAPHIC | gbzsuoiqma12000027.jpg | GRAPHIC | 462329
6 | GRAPHIC | gbzsuoiqma12000001.jpg | GRAPHIC | 471574
7 | GRAPHIC | gbzsuoiqma12000008.jpg | GRAPHIC | 206068
8 | GRAPHIC | gbzsuoiqma12000011.jpg | GRAPHIC | 336783
9 | GRAPHIC | gbzsuoiqma12000009.jpg | GRAPHIC | 256566
10 | GRAPHIC | gbzsuoiqma12000002.jpg | GRAPHIC | 476888
11 | GRAPHIC | gbzsuoiqma12000021.jpg | GRAPHIC | 240640
12 | GRAPHIC | gbzsuoiqma12000007.jpg | GRAPHIC | 263720
13 | GRAPHIC | gbzsuoiqma12000025.jpg | GRAPHIC | 266237
14 | GRAPHIC | gbzsuoiqma12000013.jpg | GRAPHIC | 283686
15 | GRAPHIC | gbzsuoiqma12000014.jpg | GRAPHIC | 322545
16 | GRAPHIC | gbzsuoiqma12000024.jpg | GRAPHIC | 297269
17 | GRAPHIC | gbzsuoiqma12000023.jpg | GRAPHIC | 152312
18 | GRAPHIC | gbzsuoiqma12000012.jpg | GRAPHIC | 283516
19 | GRAPHIC | gbzsuoiqma12000005.jpg | GRAPHIC | 236400
20 | GRAPHIC | gbzsuoiqma12000010.jpg | GRAPHIC | 212661
21 | GRAPHIC | gbzsuoiqma12000019.jpg | GRAPHIC | 93665
22 | GRAPHIC | gbzsuoiqma12000020.jpg | GRAPHIC | 220209
23 | GRAPHIC | gbzsuoiqma12000016.jpg | GRAPHIC | 304526
24 | GRAPHIC | gbzsuoiqma12000003.jpg | GRAPHIC | 333754
25 | GRAPHIC | gbzsuoiqma12000026.jpg | GRAPHIC | 333754
26 | GRAPHIC | gbzsuoiqma12000018.jpg | GRAPHIC | 313007
27 | GRAPHIC | gbzsuoiqma12000015.jpg | GRAPHIC | 306294
28 | GRAPHIC | gbzsuoiqma12000017.jpg | GRAPHIC | 233859
29 | GRAPHIC | gbzsuoiqma12000022.jpg | GRAPHIC | 249187
| Complete submission text file | 0001564590-19-008641.txt |  | 10516088

Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 19694710
SIC: 2835 In Vitro & In Vivo Diagnostic Substances